Form 4 for ARQT Arcutis Biotherapeutics, Inc.

Accepted 2026-06-09 21:21:14 ET · period of report 2026-06-05 · accession 0001628280-26-042043 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-06-09 21:21	2026-06-05	ARQT	Leonard Keith R	Dir	A - Grant	$0.00	+5,778	27.9K	+26%	$0
D	2026-06-09 21:21	2026-06-05	ARQT	Leonard Keith R	Dir	A - Grant	$0.00	+16.7K	16.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-05	A	A	5,778	$0.00	27,901	D	—	—	(F1) Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company.
2	Derivative	Stock Option (right to buy)	2026-06-05	A	A	16,667	$0.00	16,667	D	$21.23 · — to 2036-06-05	16,667 Common Stock	(F3) The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.